Cannabis Medical Research for cancer cures

While SA mulls over whether it should allow the up-scheduling of codeine-based products, there are new and cheaper alternatives on the rise. Due to the significant abuse of codeine-based products and the impact on healthcare costs, there is an investment and alternative medicinal opportunities in cannabis alkaloid based clinical trials. In the past year, investors have been expanding their portfolios in the pharmaceutical industry and developing infrastructure. This is in a bid to support medical research conducted and clinical trials for terminal illnesses such as cancer.

Guest: Dr. Shiksha Gallow - Medical Director | Biodata

Guest Mike Singer - Head of Acquisition | Labat Africa